๎๊ฒ์
๎๊ฒ์
๎
Neurosense Therapeutics Ltd
NRSN๎ญ๊ด์ฌ ๋ชฉ๋ก์ ์ถ๊ฐ
0.465USD
-0.011-2.27%
์ข
๊ฐย 07-31 16:00๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
15.15M์๊ฐ์ด์ก
์์คP/E TTM
์์ธํ ๋ด์ฉ์ Neurosense Therapeutics Ltd ํ์ฌ
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Neurosense Therapeutics Ltd ์ ๋ณด
๎์ข
๋ชฉ ์ฝ๋ NRSN
ํ์ฌ ์ด๋ฆNeurosense Therapeutics Ltd
์์ฅ์ผDec 09, 2021
CEOBen-Noon (Alon)
์ง์ ์15
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃDec 09
์ฃผ์11 Hamenofim St.
๋์HERZLIYA
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐIsrael
์ฐํธ ๋ฒํธ4672562
์ ํ97297996183
์น์ฌ์ดํธhttps://www.neurosense-tx.com/
์ข
๋ชฉ ์ฝ๋ NRSN
์์ฅ์ผDec 09, 2021
CEOBen-Noon (Alon)
Neurosense Therapeutics Ltd์ ํ์ฌ ์์์ง
๎์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
4.43M
+5.65%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
1.50M
+16.62%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
617.63K
+69.30%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
325.95K
+80.37%
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
207.90K
+88.46%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
4.43M
+5.65%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
1.50M
+16.62%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
617.63K
+69.30%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
325.95K
+80.37%
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
207.90K
+88.46%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
์์ฃผ ๋ฌป๋ ์ง๋ฌธ
Neurosense Therapeutics Ltd์ ์์ 5๋ ์ฃผ์ฃผ๋ ๋๊ตฌ์ธ๊ฐ์?
๎Neurosense Therapeutics Ltd์ ์์ 5๋ ์ฃผ์ฃผ๋ ๋ค์๊ณผ ๊ฐ์ต๋๋ค: Mr. Alon Ben-Noon
Neurosense Therapeutics Ltd(NRSN)์ ์ฃผ์์ ๋ณด์ ํ ๊ธฐ๊ด์ ๋ช ๊ฐ์ ๋๊น?
๎2026Q1 ๊ธฐ์ค์ผ๋ก, Neurosense Therapeutics Ltd์ ์ฃผ์์ ๋ณด์ ํ ๊ธฐ๊ด์ ์ด 33๊ณณ์ด๋ฉฐ, ์ด๋ค์ด ๋ณด์ ํ ์ฃผ์์ ์ด ๊ฐ์น๋ ์ฝ 367.79K๋ก ์ ์ฒด ๋ฐํ ์ฃผ์์ 1.04%๋ฅผ ์ฐจ์งํฉ๋๋ค. ์ด๋ 2025Q4 ๋๋น -2009158.00 ์ฆ๊ฐํ ์์น์
๋๋ค.